{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:43:29Z","timestamp":1790682209448,"version":"4.1.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,8,28]],"date-time":"2014-08-28T00:00:00Z","timestamp":1409184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s12035-014-8873-8","type":"journal-article","created":{"date-parts":[[2014,8,26]],"date-time":"2014-08-26T23:25:38Z","timestamp":1409095538000},"page":"353-362","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Intracerebral Administration of BDNF Protects Rat Brain Against Oxidative Stress Induced by Ouabain in an Animal Model of Mania"],"prefix":"10.1007","volume":"52","author":[{"given":"Samira S.","family":"Valvassori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila O.","family":"Arent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda V.","family":"Steckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger B.","family":"Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano K.","family":"Jornada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula T.","family":"Tonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiane","family":"Budni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edemilson","family":"Mariot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1vio","family":"Kapczinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Quevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,28]]},"reference":[{"key":"8873_CR1","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1176\/appi.ajp.160.12.2099","volume":"160","author":"M Tohen","year":"2003","unstructured":"Tohen M, Zarate CA Jr, Hennen J, Khalsa HM, Strakowski SM, Gebre-Medhin P, Salvatore P, Baldessarini RJ (2003) The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry 160:2099\u20132107","journal-title":"Am J Psychiatry"},{"key":"8873_CR2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1399-5618.2005.00207.x","volume":"7","author":"A Fagiolini","year":"2005","unstructured":"Fagiolini A, Kupfer DJ, Masalehdan A, Scott JA, Houck PR, Frank E (2005) Functional impairment in the remission phase of bipolar disorder. Bipolar Disord 7:281\u2013285","journal-title":"Bipolar Disord"},{"key":"8873_CR3","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2165\/00019053-200523060-00005","volume":"23","author":"DA Revicki","year":"2005","unstructured":"Revicki DA, Matza LS, Flood E, Lloyd A (2005) Bipolar disorder and health-related quality of life: review of burden of disease and clinical trials. Pharmacoeconomics 23:583\u2013594","journal-title":"Pharmacoeconomics"},{"key":"8873_CR4","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.biopsych.2005.10.021","volume":"59","author":"CA Zarate Jr","year":"2006","unstructured":"Zarate CA Jr, Singh J, Manji HK (2006) Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder. Biol Psychiatry 59:1006\u20131020","journal-title":"Biol Psychiatry"},{"key":"8873_CR5","doi-asserted-by":"crossref","first-page":"13290","DOI":"10.1073\/pnas.95.22.13290","volume":"95","author":"D Ong\u00fcr","year":"1998","unstructured":"Ong\u00fcr D, Drevets WC, Price JL (1998) Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A 95:13290\u201313295","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8873_CR6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10571-006-9128-7","volume":"27","author":"L Liu","year":"2007","unstructured":"Liu L, Schulz SC, Lee S, Reutiman TJ, Fatemi SH (2007) Hippocampal CA1 pyramidal cell size is reduced in bipolar disorder. Cell Mol Neurobiol 27:351\u2013358","journal-title":"Cell Mol Neurobiol"},{"key":"8873_CR7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.schres.2007.04.014","volume":"94","author":"VM Vostrikov","year":"2007","unstructured":"Vostrikov VM, Uranova NA, Orlovskaya DD (2007) Deficit of perineuronal oligodendrocytes in the frontal cortex in schizophrenia and mood disorders. Schizophr Res 94:273\u2013280","journal-title":"Schizophr Res"},{"key":"8873_CR8","first-page":"435","volume":"2","author":"CA Zarate Jr","year":"2005","unstructured":"Zarate CA Jr, Singh JB, Carlson PJ, Manji HK (2005) Molecular mechanisms of bipolar disorder. Nerv Syst 2:435\u2013445","journal-title":"Nerv. Syst"},{"key":"8873_CR9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pneurobio.2005.06.003","volume":"76","author":"CR Bramham","year":"2005","unstructured":"Bramham CR, Messaoudi E (2005) BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol 76:99\u2013125","journal-title":"Prog Neurobiol"},{"key":"8873_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jad.2014.05.012","volume":"166","author":"Z Tunca","year":"2014","unstructured":"Tunca Z, Ozerdem A, Ceylan D, Yal\u00e7\u0131n Y, Can G, Resmi H, Akan P, Erg\u00f6r G, Aydemir O, Cengisiz C, Kerim D (2014) Alterations in BDNF (brain derived neurotrophic factor) and GDNF (glial cell line-derived neurotrophic factor) serum levels in bipolar disorder: the role of lithium. J Affect Disord 166:193\u2013200. doi: 10.1016\/j.jad.2014.05.012","journal-title":"J Affect Disord"},{"key":"8873_CR11","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.biopsych.2006.03.070","volume":"61","author":"R Machado-Vieira","year":"2007","unstructured":"Machado-Vieira R, Dietrich MO, Leke R, Cereser VH, Zanatto V, Kapczinski F, Souza DO, Portela LV, Gentil V (2007) Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode. Biol Psychiatry 61:142\u2013144","journal-title":"Biol Psychiatry"},{"key":"8873_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jad.2014.02.038","volume":"162","author":"MA Rabie","year":"2014","unstructured":"Rabie MA, Mohsen M, Ibrahim M, El-Sawy Mahmoud R (2014) Serum level of brain derived neurotrophic factor (BDNF) among patients with bipolar disorder. J Affect Disord 162:67\u201372. doi: 10.1016\/j.jad.2014.02.038","journal-title":"J Affect Disord"},{"key":"8873_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2014.01.009","volume":"160","author":"K S\u00f6dersten","year":"2014","unstructured":"S\u00f6dersten K, P\u00e5lsson E, Ishima T, Funa K, Land\u00e9n M, Hashimoto K, \u00c5gren H (2014) Abnormality in serum levels of mature brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in mood-stabilized patients with bipolar disorder: a study of two independent cohorts. J Affect Disord 160:1\u20139. doi: 10.1016\/j.jad.2014.01.009","journal-title":"J Affect Disord"},{"key":"8873_CR14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.jad.2011.04.044","volume":"133","author":"B Soontornniyomkij","year":"2011","unstructured":"Soontornniyomkij B, Everall IP, Chana G, Tsuang MT, Achim CL, Soontornniyomkij V (2011) Tyrosine kinase B protein expression is reduced in the cerebellum of patients with bipolar disorder. J Affect Disord 133:646\u2013654. doi: 10.1016\/j.jad.2011.04.044","journal-title":"J Affect Disord"},{"key":"8873_CR15","doi-asserted-by":"publisher","first-page":"e389","DOI":"10.1038\/tp.2014.26","volume":"4","author":"MT Ray","year":"2014","unstructured":"Ray MT, Shannon Weickert C, Webster MJ (2014) Decreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disorders. Transl Psychiatry 4:e389. doi: 10.1038\/tp.2014.26","journal-title":"Transl Psychiatry"},{"key":"8873_CR16","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jpsychires.2006.07.013","volume":"41","author":"AC Andreazza","year":"2007","unstructured":"Andreazza AC, Cassini C, Rosa AR, Leite MC, de Almeida LM, Nardin P, Cunha AB, Cereser KM, Santin A, Gottfried C, Salvador M, Kapczinski F, Gon\u00e7alves CA (2007) Serum S100B and antioxidant enzymes in bipolar patients. J Psychiatr Res 41:523\u2013529","journal-title":"J Psychiatr Res"},{"key":"8873_CR17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1590\/S1516-44462008000300011","volume":"30","author":"F Kapczinski","year":"2008","unstructured":"Kapczinski F, Frey BN, Andreazza AC, Kauer-Sant\u2019Anna M, Cunha AB, Post RM (2008) Increased oxidative stress as a mechanism for decreased BDNF levels in acute manic episodes. Rev Bras Psiquiatr 30:243\u2013245","journal-title":"Rev Bras Psiquiatr"},{"key":"8873_CR18","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jpsychires.2009.11.002","volume":"44","author":"LK Jornada","year":"2010","unstructured":"Jornada LK, Moretti M, Valvassori SS, Ferreira CL, Padilha PT, Arent CO, Fries GR, Kapczinski F, Quevedo J (2010) Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain. J Psychiatr Res 44:506\u2013510. doi: 10.1016\/j.jpsychires.2009.11.002","journal-title":"J Psychiatr Res"},{"key":"8873_CR19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jpsychires.2010.05.011","volume":"45","author":"LK Jornada","year":"2011","unstructured":"Jornada LK, Valvassori SS, Steckert AV, Moretti M, Mina F, Ferreira CL, Arent CO, Dal-Pizzol F, Quevedo J (2011) Lithium and valproate modulate antioxidant enzymes and prevent ouabain-induced oxidative damage in an animal model of mania. J Psychiatr Res 45:162\u2013168. doi: 10.1016\/j.jpsychires.2010.05.011","journal-title":"J Psychiatr Res"},{"key":"8873_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0898-6568(98)00037-0","volume":"11","author":"H Kamata","year":"1999","unstructured":"Kamata H, Hirata H (1999) Redox regulation of cellular signalling. Cell Signal 11:1\u201314","journal-title":"Cell Signal"},{"key":"8873_CR21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0891-5849(99)00242-7","volume":"28","author":"RG Allen","year":"2000","unstructured":"Allen RG, Tresini M (2000) Oxidative stress and gene regulation. Free Radic Biol Med 28:463\u2013499","journal-title":"Free Radic Biol Med"},{"key":"8873_CR22","doi-asserted-by":"crossref","first-page":"236e45","DOI":"10.1046\/j.1525-1373.1999.d01-140.x","volume":"222","author":"RA Floyd","year":"1999","unstructured":"Floyd RA (1999) Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 222:236e45","journal-title":"Proc Soc Exp Biol Med"},{"key":"8873_CR23","first-page":"425e32","volume":"64","author":"JR Calabrese","year":"2001","unstructured":"Calabrese JR, Hirschfiel RM, Reed M (2001) Impact of bipolar disorder on U.S. community sample. Journal Clinical Psychiatry 64:425e32","journal-title":"Journal Clinical Psychiatry"},{"key":"8873_CR24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004850-200403000-00006","volume":"19","author":"ME Ozcan","year":"2004","unstructured":"Ozcan ME, Gulec M, Ozerol E, Polat R, Akyol O (2004) Antioxidant enzyme activities and oxidative stress in affective disorders. Int Clin Psychopharmacol 19:89\u201395","journal-title":"Int Clin Psychopharmacol"},{"key":"8873_CR25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.pnpbp.2006.06.011","volume":"31","author":"BN Frey","year":"2007","unstructured":"Frey BN, Andreazza AC, Kunz M, Gomes FA, Quevedo J, Salvador M, Goncalves CA, Kapczinski F (2007) Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report. Prog Neuropsychopharmacol Biol Psychiatry 31:283\u2013285","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"8873_CR26","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.pnpbp.2006.12.020","volume":"31","author":"HS Gergerlioglu","year":"2007","unstructured":"Gergerlioglu HS, Savas HA, Bulbul F, Selek S, Uz E, Yumru M (2007) Changes in nitric oxide level and superoxide dismutase activity during antimanic treatment. Prog Neuropsychopharmacol Biol Psychiatry 31:697\u2013702","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"8873_CR27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2165\/00002512-200118090-00004","volume":"18","author":"B Halliwell","year":"2001","unstructured":"Halliwell B (2001) Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18:685\u2013716","journal-title":"Drugs Aging"},{"key":"8873_CR28","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1515\/BC.2003.059","volume":"384","author":"R Dringen","year":"2003","unstructured":"Dringen R, Hirrlinger J (2003) Glutathione pathways in the brain. Biol Chem 384:505\u2013516","journal-title":"Biol Chem"},{"key":"8873_CR29","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1476-5381.2011.01318.x","volume":"164","author":"JW Young","year":"2011","unstructured":"Young JW, Henry BL, Geyer MA (2011) Predictive animal models of mania: hits, misses and future directions. Br J Pharmacol 164:1263\u20131284","journal-title":"Br J Pharmacol"},{"key":"8873_CR30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0006-3223(94)00201-D","volume":"37","author":"RS El-Mallakh","year":"1995","unstructured":"El-Mallakh RS, Wyatt RJ (1995) The Na, K-ATPase hypothesis for bipolar illness. Biol Psychiatry 37:235\u2013244","journal-title":"Biol Psychiatry"},{"key":"8873_CR31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.pnpbp.2003.10.015","volume":"28","author":"R Machado-Vieira","year":"2004","unstructured":"Machado-Vieira R, Kapczinski F, Soares JC (2004) Perspectives for the development of animalmodels of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 28:209\u2013224","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"8873_CR32","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.neuint.2009.05.003","volume":"55","author":"RE Riegel","year":"2009","unstructured":"Riegel RE, Valvassori SS, Elias G, R\u00e9us GZ, Steckert AV, de Souza B, Petronilho F, Gavioli EC, Dal-Pizzol F, Quevedo J (2009) Animal model of mania induced by ouabain: evidence of oxidative stress in submitochondrial particles of the rat brain. Neurochem Int 55:491\u2013495","journal-title":"Neurochem Int"},{"key":"8873_CR33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ijdevneu.2010.02.002","volume":"28","author":"RE Riegel","year":"2010","unstructured":"Riegel RE, Valvassori SS, Moretti M, Ferreira CL, Steckert AV, de Souza B, Dal-Pizzol F, Quevedo J (2010) Intracerebroventricular ouabain administration induces oxidative stress in the rat brain. Int J Dev Neurosci 28:233\u2013237. doi: 10.1016\/j.ijdevneu.2010.02.002","journal-title":"Int J Dev Neurosci"},{"key":"8873_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1590\/S0101-60832012000500002","volume":"39","author":"LK Jornada","year":"2012","unstructured":"Jornada LK, Valvassori SS, Resende WR, Moretti M, Ferreira CL, Fries GR, Kapczinski F, Quevedo J (2012) Decreased BDNF levels in amygdala and hippocampus after intracerebroventricular administration of ouabain. Rev Psiquiatr Cl\u00edn 39:157\u2013160. doi: 10.1590\/S0101-60832012000500002","journal-title":"Rev Psiquiatr Cl\u00edn"},{"key":"8873_CR35","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jad.2009.09.018","volume":"123","author":"MO Huff","year":"2010","unstructured":"Huff MO, Li XP, Ginns E, El-Mallakh RS (2010) Effect of ethacrynic acid on the sodium- and potassium-activated adenosine triphosphatase activity and expression in Old Order Amish bipolar individuals. J Affect Disord 123:303\u2013307. doi: 10.1016\/j.jad.2009.09.018","journal-title":"J Affect Disord"},{"key":"8873_CR36","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.pnpbp.2011.12.006","volume":"37","author":"U Banerjee","year":"2012","unstructured":"Banerjee U, Dasgupta A, Rout JK, Singh OP (2012) Effects of lithium therapy on Na + \u2212K + \u2212ATPase activity and lipid peroxidation in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 37:56\u201361. doi: 10.1016\/j.pnpbp.2011.12.006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"8873_CR37","volume-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"1986","unstructured":"Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic, San Diego"},{"key":"8873_CR38","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1034\/j.1399-5618.2003.00053.x","volume":"5","author":"RS El-Mallakh","year":"2003","unstructured":"El-Mallakh RS, El-Masri MA, Huff MO, Li XP, Decker S, Levy RS (2003) Intracerebroventricular administration of ouabain as a model of mania in rats. Bipolar Disord 5:362\u2013365","journal-title":"Bipolar Disord"},{"key":"8873_CR39","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1101\/lm.27305","volume":"12","author":"M Alonso","year":"2005","unstructured":"Alonso M, Bekinschtein P, Cammarota M, Vianna MR, Izquierdo I, Medina JH (2005) Endogenous BDNF is required for long-term memory formation in the rat parietal cortex. Learn Mem 12:504\u2013510","journal-title":"Learn Mem"},{"key":"8873_CR40","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1037\/0033-2909.83.3.482","volume":"83","author":"RN Walsh","year":"1976","unstructured":"Walsh RN, Cummins RA (1976) The open-field test: a critical review. Psychol Bull 83:482\u2013504","journal-title":"Psychol Bull"},{"key":"8873_CR41","first-page":"228","volume":"251","author":"FR Capaz","year":"1981","unstructured":"Capaz FR, Vanconcellos LE, De Moraes S, Neto JP (1981) The open field: a simple method to show ethanol withdrawal symptoms. Arch Int Pharmacodyn Ther 251:228\u2013236","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"8873_CR42","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0076-6879(90)86134-H","volume":"186","author":"H Esterbauer","year":"1990","unstructured":"Esterbauer H, Cheeseman KH (1990) Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186:407\u2013421","journal-title":"Methods Enzymol"},{"key":"8873_CR43","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0076-6879(94)33040-9","volume":"233","author":"RL Levine","year":"1994","unstructured":"Levine RL, Williams JA, Stadtman ER, Shacter E (1994) Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 233:346\u2013357","journal-title":"Methods Enzymol"},{"key":"8873_CR44","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"key":"8873_CR45","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0278-5846(99)00111-6","volume":"24","author":"S Decker","year":"2000","unstructured":"Decker S, Grider G, Cobb M, Li XP, Huff MO, El-Mallakh RS, Levy RS (2000) Open field is more sensitive than automated activity monitor in documenting ouabain-induced hyperlocomotion in the development of an animal model for bipolar illness. Prog Neuropsychopharmacol Biol Psychiatry 24:455\u2013462","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"8873_CR46","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0031-9384(97)00457-5","volume":"63","author":"DJ Ruktanonchai","year":"1998","unstructured":"Ruktanonchai DJ, El-Mallakh RS, Li R, Levy RS (1998) Persistent hyperactivity following a single intracerebroventricular dose of ouabain. Physiol Behav 63:403\u2013406","journal-title":"Physiol Behav"},{"key":"8873_CR47","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.neubiorev.2007.04.001","volume":"31","author":"L Herman","year":"2007","unstructured":"Herman L, Hougland T, El-Mallakh RS (2007) Mimicking human bipolar ion dysregulation models mania in rats. Neurosci Biobehav Rev 31:874\u2013881","journal-title":"Neurosci Biobehav Rev"},{"key":"8873_CR48","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.neuroscience.2012.08.034","volume":"239","author":"JD Gray","year":"2013","unstructured":"Gray JD, Milner TA, McEwen BS (2013) Dynamic plasticity: the role of glucocorticoids, brain-derived neurotrophic factor and other trophic factors. Neuroscience 239:214\u2013227. doi: 10.1016\/j.neuroscience.2012.08.034","journal-title":"Neuroscience"},{"key":"8873_CR49","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1399-5618.2009.00733.x","volume":"11","author":"VV Dias","year":"2009","unstructured":"Dias VV, Brissos S, Frey BN, Andreazza AC, Cardoso C, Kapczinski F (2009) Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder. Bipolar Disord 11:663\u2013671","journal-title":"Bipolar Disord"},{"key":"8873_CR50","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.biopsych.2012.10.023","volume":"73","author":"D Suri","year":"2013","unstructured":"Suri D, Veenit V, Sarkar A, Thiagarajan D, Kumar A, Nestler EJ, Galande S, Vaidya VA (2013) Early stress evokes age-dependent biphasic changes in hippocampal neurogenesis, BDNF expression, and cognition. Biol Psychiatry 73:658\u2013666. doi: 10.1016\/j.biopsych.2012.10.023","journal-title":"Biol Psychiatry"},{"key":"8873_CR51","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1034\/j.1399-5618.2002.01179.x","volume":"4","author":"DM Chuang","year":"2002","unstructured":"Chuang DM, Chen RW, Chalecka-Franaszek E, Ren M, Hashimoto R, Senatorov V, Kanai H, Hough C, Hiroi T, Leeds P (2002) Neuroprotective effects of lithium in cultured cells and animal models of diseases. Bipolar Disord 4:129\u2013136","journal-title":"Bipolar Disord"},{"key":"8873_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0327(00)00361-X","volume":"69","author":"X Li","year":"2002","unstructured":"Li X, Ketter TA, Frye MA (2002) Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders? J Affect Disord 69:1\u201314","journal-title":"J Affect Disord"},{"key":"8873_CR53","first-page":"326","volume":"31","author":"BN Frey","year":"2006","unstructured":"Frey BN, Valvassori SS, Reus GZ, Martins MR, Petronilho FC, Bardini K, Dal-Pizzol F, Kapczinski F, Quevedo J (2006) Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. J Psychiatry Neurosci 31:326\u2013332","journal-title":"J Psychiatry Neurosci"},{"key":"8873_CR54","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0028-3908(02)00215-0","volume":"43","author":"P Sarno De","year":"2002","unstructured":"De Sarno P, Li X, Jope RS (2002) Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. Neuropharmacology 43:1158\u20131164","journal-title":"Neuropharmacology"},{"key":"8873_CR55","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.tips.2004.07.006","volume":"25","author":"L Meijer","year":"2004","unstructured":"Meijer L, Flajolet M, Greengard P (2004) Pharmacological inhibitors of glycogen synthase kinase 3. Trends Pharmacol Sci 25:471\u2013480","journal-title":"Trends Pharmacol Sci"},{"key":"8873_CR56","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.1111\/febs.12407","volume":"280","author":"AR Cole","year":"2013","unstructured":"Cole AR (2013) Glycogen synthase kinase 3 substrates in mood disorders and schizophrenia. FEBS J 280:5213\u20135227. doi: 10.1111\/febs.12407","journal-title":"FEBS J"},{"key":"8873_CR57","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s11920-008-0081-7","volume":"10","author":"N DiazGranados","year":"2008","unstructured":"DiazGranados N, Zarate CA Jr (2008) A review of the preclinical and clinical evidence for protein kinase C as a target for drug development for bipolar disorder. Curr Psychiatry Rep 10:510\u2013519","journal-title":"Curr Psychiatry Rep"},{"key":"8873_CR58","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jad.2010.08.015","volume":"129","author":"Z Amrollahi","year":"2011","unstructured":"Amrollahi Z, Rezaei F, Salehi B, Modabbernia AH, Maroufi A, Esfandiari GR, Naderi M, Ghebleh F, Ahmadi-Abhari SA, Sadeghi M, Tabrizi M, Akhondzadeh S (2011) Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania. J Affect Disord 129:327\u2013331. doi: 10.1016\/j.jad.2010.08.015","journal-title":"J Affect Disord"},{"key":"8873_CR59","doi-asserted-by":"publisher","first-page":"569","DOI":"10.2165\/00023210-200923070-00003","volume":"23","author":"CA Zarate","year":"2009","unstructured":"Zarate CA, Manji HK (2009) Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder. CNS Drugs 23:569\u2013582. doi: 10.2165\/00023210-200923070-00003","journal-title":"CNS Drugs"},{"key":"8873_CR60","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1073\/pnas.0307921101","volume":"101","author":"JM Beaulieu","year":"2004","unstructured":"Beaulieu JM, Sotnikova TD, Yao WD, Kockeritz L, Woodgett JR, Gainetdinov RR, Caron MG (2004) Lithium antagonizes dopamine-dependent behaviors mediated by an AKT\/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci U S A 101:5099\u20135104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8873_CR61","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2174\/156720212799297056","volume":"9","author":"AV Steckert","year":"2012","unstructured":"Steckert AV, Valvassori SS, Mina F, Lopes-Borges J, Varela RB, Kapczinski F, Dal-Pizzol F, Quevedo J (2012) Protein kinase C and oxidative stress in an animal model of mania. Curr Neurovasc Res 9:47\u201357. doi: 10.2174\/156720212799297056","journal-title":"Curr Neurovasc Res"},{"key":"8873_CR62","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00210-013-0893-9","volume":"386","author":"L Caberlotto","year":"2013","unstructured":"Caberlotto L, Carboni L, Zanderigo F, Andreetta F, Andreoli M, Gentile G, Razzoli M (2013) Differential effects of glycogen synthase kinase 3 (GSK3) inhibition by lithium or selective inhibitors in the central nervous system. Naunyn Schmiedebergs Arch Pharmacol 386:893\u2013903. doi: 10.1007\/s00210-013-0893-9","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"8873_CR63","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1111\/j.1460-9568.2004.03246.x","volume":"19","author":"A Wu","year":"2004","unstructured":"Wu A, Ying Z, Gomez-Pinilla F (2004) The interplay between oxidative stress and brain-derived neurotrophic factor modulates the outcome of a saturated fat diet on synaptic plasticity and cognition. Eur J Neurosci 19:1699\u20131707","journal-title":"Eur J Neurosci"},{"key":"8873_CR64","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.biopsych.2005.04.052","volume":"58","author":"L Shao","year":"2005","unstructured":"Shao L, Young LT, Wang JF (2005) Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells. Biol Psychiatry 58:879\u2013884","journal-title":"Biol Psychiatry"},{"key":"8873_CR65","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s10571-011-9686-1","volume":"31","author":"IK Hwang","year":"2011","unstructured":"Hwang IK, Yoo KY, Yoo DY, Choi JW, Lee CH, Choi JH, Yoon YS, Won MH (2011) Time-course of changes in phosphorylated CREB in neuroblasts and BDNF in the mouse dentate gyrus at early postnatal stages. Cell Mol Neurobiol 31:669\u2013674. doi: 10.1007\/s10571-011-9686-1","journal-title":"Cell Mol Neurobiol"},{"key":"8873_CR66","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1111\/acer.12104","volume":"37","author":"NI Boyadjieva","year":"2013","unstructured":"Boyadjieva NI, Sarkar DK (2013) Cyclic adenosine monophosphate and brain-derived neurotrophic factor decreased oxidative stress and apoptosis in developing hypothalamic neuronal cells: role of microglia. Alcohol Clin Exp Res 37:1370\u20131379. doi: 10.1111\/acer.12104","journal-title":"Alcohol Clin Exp Res"},{"key":"8873_CR67","doi-asserted-by":"crossref","first-page":"40398","DOI":"10.1074\/jbc.C500140200","volume":"280","author":"J Lee","year":"2005","unstructured":"Lee J, Kim CH, Simon DK, Aminova LR, Andreyev AY, Kushnareva YE, Murphy AN, Lonze BE, Kim KS, Ginty DD, Ferrante RJ, Ryu H, Ratan RR (2005) Mitochondrial cyclic AMP response element-binding protein (CREB) mediates mitochondrial gene expression and neuronal survival. J Biol Chem 280:40398\u201340401","journal-title":"J Biol Chem"},{"key":"8873_CR68","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1128\/MCB.00980-07","volume":"28","author":"A Franko","year":"2008","unstructured":"Franko A, Mayer S, Thiel G, Mercy L, Arnould T, Hornig-Do HT, Wiesner RJ, Goffart S (2008) CREB-1alpha is recruited to and mediates upregulation of the cytochrome c promoter during enhanced mitochondrial biogenesis accompanying skeletal muscle differentiation. Mol Cell Biol 28:2446\u20132459","journal-title":"Mol Cell Biol"},{"key":"8873_CR69","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0378-1119(01)00809-5","volume":"286","author":"RC Scarpulla","year":"2002","unstructured":"Scarpulla RC (2002) Transcriptional activators and coactivators in the nuclear control of mitochondrial function in mammalian cells. Gene 286:81\u201389","journal-title":"Gene"},{"key":"8873_CR70","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0891-5849(88)90109-8","volume":"5","author":"JM McCord","year":"1988","unstructured":"McCord JM, Fridovich I (1988) Superoxide dismutase: the first twenty years (1968\u20131988). Free Radic Biol Med 5:363\u2013369","journal-title":"Free Radic Biol Med"},{"key":"8873_CR71","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/BF01487101","volume":"49","author":"L Floh\u00e9","year":"1971","unstructured":"Floh\u00e9 L (1971) Glutathione peroxidase: enzymology and biological aspects. Klin Wochenschr 49:669\u2013683","journal-title":"Klin Wochenschr"},{"key":"8873_CR72","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00018-003-3206-5","volume":"61","author":"P Chelikani","year":"2004","unstructured":"Chelikani P, Fita I, Loewen PC (2004) Diversity of structures and properties among catalases. Cell Mol Life Sci 61:192\u2013208, Review","journal-title":"Cell Mol Life Sci"},{"key":"8873_CR73","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1432-1033.1977.tb11856.x","volume":"80","author":"G Krohne-Ehrich","year":"1977","unstructured":"Krohne-Ehrich G, Schirmer RH, Untucht-Grau R (1977) Glutathione reductase from human erythrocytes. Isolation of the enzyme and sequence analysis of the redox-active peptide. Eur J Biochem 80:65\u201371","journal-title":"Eur J Biochem"},{"key":"8873_CR74","first-page":"383","volume":"46","author":"WB Jakoby","year":"1978","unstructured":"Jakoby WB (1978) The glutathione S-transferases: a group of multifunctional detoxification proteins. Adv Enzymol Relat Areas Mol Biol 46:383\u2013414, Review","journal-title":"Adv Enzymol Relat Areas Mol Biol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-014-8873-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-014-8873-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-014-8873-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-014-8873-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T13:07:35Z","timestamp":1650028055000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-014-8873-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,28]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["8873"],"URL":"https:\/\/doi.org\/10.1007\/s12035-014-8873-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,28]]}}}